Assignee
GALLANT PET INC
US·3 granted patents·5 pending applications·1 citations·filing 2016–2024
Top patents by PatentIndex Score
8 records- 0171US12241088B2Uterine-derived regenerative cell compositions and uses thereofGALLANT PET INC·Filed 2024·Granted Mar 4, 2025·0 cites·20 claims
- 0266US10653397B2Vial useable in tissue extraction proceduresGALLANT PET INC·Filed 2016·Granted May 19, 2020·1 cites·8 claims
- 0364US2022096558A1Systemic, allogenic stem cell therapies for treatment of diseases in animalsGALLANT PET INC·Filed 2021·Application pending·0 cites
- 0460US12497594B2Uterine-derived regenerative cell compositions and uses thereofGALLANT PET INC·Filed 2021·Granted Dec 16, 2025·0 cites·20 claims
- 0556US2025019662A1Primed uterine-derived regenerative cell compositions and uses thereofGALLANT PET INC·Filed 2022·Application pending·0 cites
- 0656US2020383317A1Viable cell compositions, and methods related to sameGALLANT PET INC·Filed 2020·Application pending·0 cites
- 0754US2024352425A1Methods for optimizing reproductive tissue derived cell yield and viability for clinical applicationsGALLANT PET INC·Filed 2022·Application pending·0 cites
- 0853US2021252155A1Uses of trehalose in cell suspensionsGALLANT PET INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GALLANT PET INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →